BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32622720)

  • 1. Recent scenario of long non-coding RNAs as a diagnostic and prognostic biomarkers of prostate cancer.
    Shukla KK; Misra S; Sankanagoudar S; Sharma H; Choudhary GR; Pareek P; Vishnoi JR; Sharma P
    Urol Oncol; 2020 Dec; 38(12):918-928. PubMed ID: 32622720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent scenario of microRNA as diagnostic and prognostic biomarkers of prostate cancer.
    Shukla KK; Misra S; Pareek P; Mishra V; Singhal B; Sharma P
    Urol Oncol; 2017 Mar; 35(3):92-101. PubMed ID: 27890424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNAs in prostate cancer: Functional roles and clinical implications.
    Xu YH; Deng JL; Wang G; Zhu YS
    Cancer Lett; 2019 Nov; 464():37-55. PubMed ID: 31465841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of androgen-responsive lncRNAs as diagnostic and prognostic markers for prostate cancer.
    Wan X; Huang W; Yang S; Zhang Y; Pu H; Fu F; Huang Y; Wu H; Li T; Li Y
    Oncotarget; 2016 Sep; 7(37):60503-60518. PubMed ID: 27556357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long non-coding RNAs related to androgen receptor function in prostate cancer: Advances in studies].
    Wang M; Ying J; Zhang M; Liang CZ
    Zhonghua Nan Ke Xue; 2019 Aug; 25(8):739-743. PubMed ID: 32227719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor.
    Cui Z; Ren S; Lu J; Wang F; Xu W; Sun Y; Wei M; Chen J; Gao X; Xu C; Mao JH; Sun Y
    Urol Oncol; 2013 Oct; 31(7):1117-23. PubMed ID: 22264502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNAs and prostate cancer.
    Misawa A; Takayama KI; Inoue S
    Cancer Sci; 2017 Nov; 108(11):2107-2114. PubMed ID: 28796922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
    Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel lncRNA
    Lingadahalli S; Jadhao S; Sung YY; Chen M; Hu L; Chen X; Cheung E
    Mol Cancer Res; 2018 Dec; 16(12):1865-1878. PubMed ID: 30115758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Roles of long non-coding RNAs in prostate cancer and their action mechanisms].
    Li ZF; Xiao N; Yao YW; Yao ZF
    Zhonghua Nan Ke Xue; 2022 Dec; 28(12):1129-1135. PubMed ID: 37846635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNAs in prostate cancer: Biological and clinical implications.
    Das R; Feng FY; Selth LA
    Mol Cell Endocrinol; 2019 Jan; 480():142-152. PubMed ID: 30391670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA regulating androgen receptor signaling in breast and prostate cancer.
    Kumar S; Prajapati KS; Singh AK; Kushwaha PP; Shuaib M; Gupta S
    Cancer Lett; 2021 Apr; 504():15-22. PubMed ID: 33556545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer.
    Smolle MA; Bauernhofer T; Pummer K; Calin GA; Pichler M
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging Roles of Long Non-coding RNAs as Novel Biomarkers in the Diagnosis and Prognosis of Prostate Cancer.
    Kan Y; Li B; Yang D; Liu Y; Liu J; Yang C; Mao L
    Discov Med; 2021; 32(165):29-37. PubMed ID: 35219354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of long non-coding RNAs in advanced prostate cancer associated with androgen receptor splicing factors.
    Takayama KI; Fujimura T; Suzuki Y; Inoue S
    Commun Biol; 2020 Jul; 3(1):393. PubMed ID: 32704143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological bases and clinical impact of long noncoding RNAs in prostate cancer: a new budding star.
    Xu T; Lin CM; Cheng SQ; Min J; Li L; Meng XM; Huang C; Zhang L; Deng ZY; Li J
    Mol Cancer; 2018 Jul; 17(1):103. PubMed ID: 30037351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long non-coding RNAs in prostate cancer: An update].
    Wu PG; Zhang YX
    Zhonghua Nan Ke Xue; 2018 Aug; 24(8):735-739. PubMed ID: 30173435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor and miR-206 regulation in prostate cancer.
    Chua FY; Adams BD
    Transcription; 2017; 8(5):313-327. PubMed ID: 28598253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNAs in prostate cancer: overview and clinical implications.
    Malik B; Feng FY
    Asian J Androl; 2016; 18(4):568-74. PubMed ID: 27072044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetics regulation of prostate cancer: Biomarker and therapeutic potential.
    Ragavi R; Muthukumaran P; Nandagopal S; Ahirwar DK; Tomo S; Misra S; Guerriero G; Shukla KK
    Urol Oncol; 2023 Aug; 41(8):340-353. PubMed ID: 37032230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.